paj_banner

3415-08-5 L-Tyr-NCA

3415-08-5 L-Tyr-NCA

Lus piav qhia luv luv:

Qhov tshwm sim Dawb rau Off-White crystals los yog crystalline hmoov
MF C10H9 NPO 4
MW 207.18 Nws
Purity 98+


Product Detail

Kev thauj mus los & kev pom zoo shipping txoj kev:
los ntawm huab cua, los ntawm hiav txwv lossis los ntawm kev nthuav qhia

Kev cia khoom:
nert cua, Khaws rau hauv lub freezer, hauv qab -20 ° C

Yam tsawg kawg nkaus Order Qty:
Kev sib tham

Ntawv pov thawj:
COA, HPLC, GC, HNMR, Assay, Dej Cov ntsiab lus (KF), TLC muaj

D-Lys(tfa)-NCA (2)

Synonyms

Tyrosine, NCAAB;

N-Carboxy-L-tyrosine anhydride;

(4S)-4-[(4-Hydroxyphenyl)methyl]-2,5-oxazolidinedione;

L-Tyrosine N-carboxyanhydride;

(2,5-Oxazolidinedione,4-[(4-hydroxyphenyl)Methyl]-, (4S)-;

N-Carbonyl-L-Tyrosine Anhydride

Ntim sab hauv

Lawv feem ntau yog siv los ntim cov hmoov.Thiab lawv tuaj yeem tiv thaiv tshav ntuj thiab dej kom tsis txhob ua phem.

Sab hauv ntim 2
Inner packing 1
Inner packing 3

sab nrauv ntim

Lub thawv tawv tawv tuaj yeem tiv thaiv koj cov khoom los ntawm kev sib tsoo thiab ntub dej.

Kev ntim khoom sab nrauv 3
Kev ntim khoom sab nrauv 2
Kev ntim khoom sab nrauv 1

Daim ntawv thov

3415-08-5 L-Tyr-NCA is one of intermediates of Glatiramer Acetate.

Glatiramer Acetate yog cov khoom siv hluavtaws peptide tsim los ntawm plaub cov amino acids: glutamic acid, alanine, tyrosine, thiab lysine.Nws thawj daim ntawv thov yog nyob rau hauv kev kho mob Multiple Sclerosis (MS), ib tug mob ntev, inflammatory, demyelinating kab mob cuam tshuam rau hauv nruab nrab paj hlwb.Los ntawm cov txheej txheem ntawm "bypass suppression," Glatiramer Acetate exerts immunomodulatory thiab anti-inflammatory teebmeem nyob rau hauv MS, nce lub hlwb-derived neurotrophic factor (BDNF), downregulating o-induced demyelination, thiab txhawb kev loj hlob ntawm axons thiab myelin sheaths.

Thoob plaws ntiaj teb, Glatiramer Acetate tau txais kev thov dav dav.Piv txwv li, hauv Tebchaws Meskas, nws tau ua lag luam raws li lub npe Copaxone thiab tau pom zoo los ntawm Food and Drug Administration (FDA) rau kev kho mob ntau yam Sclerosis.Hauv cov teb chaws sab hnub poob uas muaj ntau yam ntawm MS, nws cov txiaj ntsig thiab kev zam tau raug lees paub dav.

Hauv Suav teb, thaum Lub Rau Hli 28, 2023, "Glatiramer Acetate Txhaj" tau txais kev pom zoo los ntawm National Medical Products Administration (NMPA) rau kev kho mob ntawm cov neeg laus uas muaj kev rov qab-remitting Multiple Sclerosis (MS), suav nrog kev kho mob cais tawm, rov qab-remitting. MS, thiab active Secondary Progressive MS.

cov khoom muaj feem xyuam

L-Gly-NCA L-Ala-NCA D-Ala-NCA L-Val-NCA
D-Leu-NCA DL-leu-NCA L-Phe-NCA D-Tyr-NCA
L-Tyr(bzl)-NCA L-Glu(Obzl)-NCA D-Asp(OBzl)-NCA L-Lys(tfa)-NCA
L-Lys(Cbz)-NCA D-Lys(Cbz)-NCA Sar-NCA

Superiority

1. R&D kev pabcuam muaj
2. ISO certified chaw tsim tshuaj paus, zoo guarantee
3.A tag nrho cov kev pabcuam tomqab muag thaum lub sijhawm tsim khoom
4.High nqi zoo
5.Cov ntaub ntawv pov thawj zoo muab rau ib tus neeg siv khoom thov
6.Kev pab cuam tom qab muag zoo, tswj kev sib raug zoo nrog cov neeg siv khoom
7.Ntau cov peev txheej los pab txo tus nqi thauj khoom
8.Dawb qauv muab los kuaj xyuas qhov zoo ua ntej kev them nyiaj
9. Lub sij hawm them nyiaj sib tham
10.Assit cov neeg muas zaub nrog cov xwm txheej hauv Suav teb


  • Yav dhau los:
  • Tom ntej:

  • Sau koj cov lus ntawm no thiab xa tuaj rau peb